ACCESS Newswire
ACCESS Newswire
More ACCESS Newswire
View Older Stories View Newer Stories-
Cardiff Lexington Appoints Matthew Shafer as Chief Financial Officer
-
Favo Capital Expands Global Footprint With Three Strategic Acquisitions
-
Generation Income Properties Announces Continued Monthly Cash Distributions
-
AllianceBernstein Receives Equality 100 Score for 8th Year
-
Regency Silver Options Two Past Producing High-Grade Silver Projects Near San Dimas in Durango, Mexico
-
Sigma Additive Solutions Completes Acquisition of Travel Technology Company NextTrip Holdings
-
SolGold PLC Announces Block Listing Six Monthly Return
-
Partnering for Sustainability: Cisco's Collaborative Approach
-
Noodle Maker Master Kong Showcases How To Cut Plastic Waste
-
Catheter Precision, Inc. (VTAK) Announces Changes to Executive Management and Board of Directors
-
iCoreConnect Inc. Announces Strategic Acquisition of FeatherPay
-
Pizza Inn and New Franchise Partner Team Up to Bring 50 New Locations to Saudi Arabia
-
Greater Boston-Based Harte Hanks Continues Growth Phase with Addition of Global Advertising Executive Elizabeth Ross to Board of Directors
-
Introducing PillSafe(R), the New 'Smart' Pill Bottle for Prescription Medication
-
NuRAN Signs a Mandate Letter for US $5M loan agreement and Extends Convertible Debenture Maturity
-
Protagonist Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
-
Creating the Greatest Place To Work for All: Chemours Recognized as a Best Chemical Company To Work for by U.S. News & World Report
-
Guanajuato Silver Appoints Danny Lee Chief Financial Officer
-
Mkango Subsidiary Maginito and CoTec Form Hypromag USA Joint Venture and Commence Process to Appoint EPCM Provider for The Feasibility Study
-
Executive Chairman Robert Friedland to Deliver a Keynote Presentation at the Future Minerals Forum in Riyadh, Saudi Arabia on January 10, 2024
-
Idaho Strategic Provides 2023 Year in Review
-
Laser Photonics Receives Order From Ontario Power Generation for MarkStar Pro Laser Marking System
-
Ares Capital Corporation Schedules Earnings Release for the Fourth Quarter and Fiscal Year Ended December 31, 2023
-
Snipp Interactive Reports 28% Revenue Growth for the 9 Months Ended September 30, 2023; Company to Hold Investor Conference Call on January 9th
-
Phoenix’s EdisonFuture Plans to Accept Payment in Bitcoin
-
Snowline Gold Expands Footprint of Widespread, Near-Surface Mineralization with Drill Results up to 308.8 m of 2.2 Grams Per Tonne Gold Including 180.3 M Of 3.2 grams per tonne gold from Surface at It
-
Ascendant Resources Inc. Announces Submission of the Environmental Impact Assessment ("EIA") for its Lagoa Salgada VMS Project, in Portugal
-
Hilbert Capital, the Quantitative Asset Manager, Releases 2023 Trading Results for its Funds
-
Electrovaya Reports Record Revenue of $44.1 Million for Fiscal Year 2023; Up 171% Y/Y
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program
-
Tortoise Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023, for TYG, NTG, TTP, NDP and TPZ
-
TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023
-
Runway Influence Tops the Charts in Influencer Marketing: Unlocking Social Media Growth Strategies
-
IBC Advanced Alloys Reports Results from its 2023 Annual General Meeting
-
Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange
-
Clean Air Metals Files Interim Financial Statements for the Nine Months Ended October 31, 2023
-
NESR Announces Participation in Upcoming Conferences
